MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-19-2025
Dynatronics Corporation Total Assets 2011-2026 | DYNT
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Dynatronics Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.4 M | 25.9 M | 30.1 M | 35.4 M | 39.1 M | 37.6 M | 39.6 M | 42.1 M | 26.1 M | 15.3 M | 19.2 M | 14.3 M | 15.1 M | 15.3 M | 14.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 42.1 M | 14.3 M | 25.7 M |
Quarterly Total Assets Dynatronics Corporation
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 M | 15.4 M | 25.8 M | 25.1 M | 25.9 M | 29.3 M | 30.3 M | 30.1 M | 33.4 M | 35 M | 35 M | 35.4 M | 37.5 M | 37.7 M | 39.5 M | 39.1 M | 39.9 M | 37.6 M | 36.8 M | 37.6 M | 37.6 M | 42 M | 42.4 M | 39.6 M | 39.6 M | 38.7 M | 41 M | 42.1 M | 42.1 M | 45.6 M | 31.7 M | 26.1 M | 26.1 M | 16.4 M | 15.3 M | 15.3 M | 15.3 M | 16.9 M | 17.1 M | 19.2 M | 19.2 M | 17.7 M | 18.3 M | 14.3 M | 14.3 M | 15.1 M | 14.9 M | 15.1 M | 15.1 M | 15.4 M | 15.2 M | 15.3 M | 15.3 M | 15 M | 15.1 M | 14.8 M | 14.8 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 45.6 M | 14.3 M | 26.6 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
6.21 B | $ 176.83 | 5.97 % | $ 13.2 B |  USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 11.66 | 5.71 % | $ 1.75 B | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
AxoGen
AXGN
|
222 M | $ 34.0 | 9.71 % | $ 1.57 B | USA |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 12.18 | 2.01 % | $ 1.65 B | USA |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
9.36 B | $ 281.15 | 1.13 % | $ 7.93 B | USA |
 |
Second Sight Medical Products
EYES
|
39.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Bruker Corporation
BRKR
|
5.81 B | $ 38.25 | 4.31 % | $ 5.7 K | USA |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 62.56 | 1.15 % | $ 92.6 B | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Electromed
ELMD
|
53.8 M | $ 24.4 | 2.61 % | $ 206 M | USA |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 9.17 | 1.1 % | $ 260 M | USA |
 |
Globus Medical
GMED
|
5.3 B | $ 91.96 | 2.13 % | $ 12.4 B | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
256 M | $ 4.14 | 2.22 % | $ 876 M | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Nevro Corp.
NVRO
|
554 M | - | - | $ 217 M | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.62 | 1.67 % | $ 38.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
91.5 M | $ 3.37 | -0.88 % | $ 126 M |  France |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 9.85 | 1.86 % | $ 353 M | USA |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 36.59 | 5.94 % | $ 1.14 B | USA |
 |
FONAR Corporation
FONR
|
199 M | $ 18.62 | 0.22 % | $ 122 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
13.7 B | $ 81.71 | 1.08 % | $ 47.8 B | USA |
 |
Inspire Medical Systems
INSP
|
907 M | $ 53.38 | -1.89 % | $ 1.57 B | USA |
 |
Varex Imaging Corporation
VREX
|
1.11 B | $ 11.04 | 4.25 % | $ 457 M | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 1.88 | 2.73 % | $ 1.14 M | USA |
 |
Inogen
INGN
|
299 M | $ 6.67 | -1.91 % | $ 177 M | USA |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.03 | - | $ 17.4 M | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 87.48 | 2.78 % | $ 3.04 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 16.01 | 1.59 % | $ 376 M | USA |